#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia Leukocyte adhesion deficiency Myeloproliferative neoplasm Neurodevelopmental disorder Osteosarcoma metastatic Glycogen storage disease type V Advanced systemic mastocytosis Essential thrombocythaemia Skin angiosarcoma Chronic graft versus host disease Facioscapulohumeral muscular dystrophy Carcinoid syndrome Hodgkin's disease recurrent Oesophageal achalasia Lymphangioma More trials…

    Learn about Rare Diseases

    IgA nephropathy – Diagnostics Langerhans cell sarcoma – Basic Information Marginal zone lymphoma – Life with Disease Hairy cell leukaemia recurrent – Trials in Disease Gastrointestinal stromal tumour Andersen-Tawil syndrome – Trials in Disease Glycogen storage disease type I – Life with Disease Chordoma – Treatment Ewing’s sarcoma metastatic – Basic Information Leukoencephalopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecoo16 Fampridine Nystatin Ganciclovir Sodium Acoramidis Hydrochloride Nefopam Human Vaccinia Immunoglobulin Ergocalciferol Bp Cilazapril Carbamazepine (Ph. Eur.) Tiapride Leniolisib Phosphate Diclofenac Certolizumab Pegol Itolizumab ARTICAINE HYDROCHLORIDE Moxifloxacin Sodium Sulfate Anhydrous Adg126 Prednisolone Sodium Phosphate More therapies…

    Learn about Your Condition

    Elderly Small fibre neuropathy Hereditary optic atrophy Breast cancer stage I Pulmonary sarcoidosis Diabetic retinal oedema Brain neoplasm Iron overload Primary hypercholesterolaemia Diabetic gastroparesis Injection site pain Asymptomatic HIV infection Optic atrophy Complicated appendicitis Testicular leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Migraine

  • Study on Atogepant for Preventing Menstrual Migraine in Women

    Not recruiting

    3 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atogepant
    Czechia Germany Hungary Italy Poland Portugal +1

  • Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

    Not recruiting

    2 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Lu Ag09222
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Rimegepant
    Austria Belgium Denmark Finland France Germany +4

  • Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Rimegepant
    Austria Belgium Denmark Finland Germany Italy +3

  • Study on the Effectiveness of Fremanezumab for Preventing Migraines in Children and Teens Aged 6 to 17

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Fremanezumab
    Finland Germany Italy The Netherlands Poland Spain

  • Study on Migraine: Effects of Fremanezumab on Brain Chemistry in Patients with and without Aura

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Fremanezumab
    Austria
Previous Page
1 … 4 5 6 7 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!